{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:41:31Z","timestamp":1784234491689,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"publisher","award":["84060-CAN-13"],"award-info":[{"award-number":["84060-CAN-13"]}],"id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TA188 \/1-2"],"award-info":[{"award-number":["TA188 \/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.bone.2019.115036","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T11:48:53Z","timestamp":1565696933000},"page":"115036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Novel ActRIIB ligand trap increases muscle mass and improves bone geometry in a mouse model of severe osteogenesis imperfecta"],"prefix":"10.1016","volume":"128","author":[{"given":"Josephine T.","family":"Tauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-0360","authenticated-orcid":false,"given":"Frank","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10028","key":"10.1016\/j.bone.2019.115036_bb0005","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","article-title":"Osteogenesis imperfecta","volume":"387","author":"Forlino","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.bone.2019.115036_bb0010","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1007\/s00198-016-3709-1","article-title":"DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum","volume":"27","author":"Bardai","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bone.2019.115036_bb0015","doi-asserted-by":"crossref","first-page":"E356","DOI":"10.1210\/jc.2013-3209","article-title":"Muscle anatomy and dynamic muscle function in osteogenesis imperfecta type I","volume":"99","author":"Veilleux","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2019.115036_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bone.2015.05.019","article-title":"The functional muscle-bone unit in patients with osteogenesis imperfecta type I","volume":"79","author":"Veilleux","year":"2015","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2019.115036_bb0025","first-page":"1","article-title":"Muscle abnormalities in osteogenesis imperfecta","volume":"17","author":"Veilleux","year":"2017","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"9","key":"10.1016\/j.bone.2019.115036_bb0030","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nm.3917","article-title":"Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice","volume":"21","author":"Dankbar","year":"2015","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bone.2019.115036_bb0035","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bone.2007.02.012","article-title":"Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading","volume":"40","author":"Hamrick","year":"2007","journal-title":"Bone"},{"issue":"22","key":"10.1016\/j.bone.2019.115036_bb0040","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1007\/s00018-014-1689-x","article-title":"Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways","volume":"71","author":"Rodriguez","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bone.2019.115036_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15153","article-title":"Activin A more prominently regulates muscle mass in primates than does GDF8","volume":"8","author":"Latres","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2019.115036_bb0050","doi-asserted-by":"crossref","unstructured":"R.D. Alves, K. Eijken M Fau-Bezstarosti, J.A.A. Bezstarosti K Fau-Demmers, J.P.T.M. Demmers Ja Fau-van Leeuwen, J.P. van Leeuwen, Activin A suppresses osteoblast mineralization capacity by altering extracellular matrix (ECM) composition and impairing matrix vesicle (MV) production, (1535\u20139484 (Electronic)) (2013).","DOI":"10.1074\/mcp.M112.024927"},{"issue":"9","key":"10.1016\/j.bone.2019.115036_bb0055","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.cellsig.2011.05.003","article-title":"Myostatin: a novel insight into its role in metabolism, signal pathways, and expression regulation","volume":"23","author":"Huang","year":"2011","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.bone.2019.115036_bb0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11914-013-0160-5","article-title":"Myostatin\u2014the holy grail for muscle, bone, and fat?","volume":"11","author":"Buehring","year":"2013","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"10.1016\/j.bone.2019.115036_bb0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ar.a.10044","article-title":"Increased bone mineral density in the femora of GDF8 knockout mice","volume":"272","author":"Hamrick","year":"2003","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"issue":"3","key":"10.1016\/j.bone.2019.115036_bb0070","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1359\/JBMR.051203","article-title":"Increased muscle mass with myostatin deficiency improves gains in bone strength with exercise","volume":"21","author":"Hamrick","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"6520","key":"10.1016\/j.bone.2019.115036_bb0075","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/374354a0","article-title":"Functional analysis of activins during mammalian development","volume":"374","author":"Matzuk","year":"1995","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bone.2019.115036_bb0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00198-015-3226-7","article-title":"Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice","volume":"27","author":"Oestreich","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2019.115036_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/boneres.2014.42","article-title":"Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta","volume":"3","author":"DiGirolamo","year":"2015","journal-title":"Bone research"},{"issue":"10","key":"10.1016\/j.bone.2019.115036_bb0090","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/jbmr.3473","article-title":"Skeletal response to soluble activin receptor type IIB in mouse models of osteogenesis imperfecta","volume":"33","author":"Jeong","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2019.115036_bb0095","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mus.25706","article-title":"Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function","volume":"57","author":"Jeong","year":"2018","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.bone.2019.115036_bb0100","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/jbmr.2177","article-title":"First mouse model for combined osteogenesis imperfecta and Ehlers-Danlos syndrome","volume":"29","author":"Chen","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2019.115036_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2019.115036_bb0110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","article-title":"ImageJ2: ImageJ for the next generation of scientific image data","volume":"18","author":"Rueden","year":"2017","journal-title":"BMC Bioinformatics"},{"issue":"19","key":"10.1016\/j.bone.2019.115036_bb0115","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1073\/pnas.91.19.8817","article-title":"Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice","volume":"91","author":"Matzuk","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.bone.2019.115036_bb0120","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1096\/fj.201600271RR","article-title":"ActRIIB blockade increases force-generating capacity and preserves energy supply in exercising mdx mouse muscle in vivo","volume":"30","author":"Bechir","year":"2016","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.bone.2019.115036_bb0125","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/gerona\/glt030","article-title":"Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents","volume":"68","author":"Chiu","year":"2013","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.bone.2019.115036_bb0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/ars.2013.5773","article-title":"Exercise-induced skeletal muscle remodeling and metabolic adaptation: redox signaling and role of autophagy","volume":"21","author":"Ferraro","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.bone.2019.115036_bb0135","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2013.385","article-title":"Bone marrow monocyte-\/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma","volume":"28","author":"Silbermann","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bone.2019.115036_bb0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/bbrc.1993.2006","article-title":"Activin enhances osteoclast-like cell formation in vitro","volume":"195","author":"Sakai","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bone.2019.115036_bb0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1006\/bbrc.2000.2075","article-title":"Activin A is an essential cofactor for osteoclast induction","volume":"268","author":"Fuller","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bone.2019.115036_bb0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/endo.143.1.8580","article-title":"Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures","volume":"143","author":"Gaddy-Kurten","year":"2002","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.bone.2019.115036_bb0155","first-page":"683","article-title":"Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures","volume":"128","author":"Fowler","year":"2015","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.bone.2019.115036_bb0160","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1096\/fj.14-257543","article-title":"The effects of an ActRIIb receptor Fc fusion protein ligand trap in juvenile simian immunodeficiency virus-infected rhesus macaques","volume":"29","author":"O'Connell","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2019.115036_bb0165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/B978-0-12-385961-7.00011-1","article-title":"Activin in glucose metabolism","volume":"85","author":"Hashimoto","year":"2011","journal-title":"Vitam. Horm."},{"issue":"1","key":"10.1016\/j.bone.2019.115036_bb0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00125-013-3079-6","article-title":"Differential regulation of mouse pancreatic islet insulin secretion and Smad proteins by activin ligands","volume":"57","author":"Wu","year":"2014","journal-title":"Diabetologia"},{"issue":"Supplement 2","key":"10.1016\/j.bone.2019.115036_bb0175","first-page":"S218","article-title":"G.P.107 - ACE-2494, a novel GDF ligand trap, increases muscle and bone mass upon systemic administration in mice","volume":"25","author":"Pearsall","year":"2015","journal-title":"Neuromuscul. Disord."},{"issue":"33","key":"10.1016\/j.bone.2019.115036_bb0180","doi-asserted-by":"crossref","first-page":"13809","DOI":"10.1074\/jbc.M117.782128","article-title":"Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass","volume":"292","author":"Goh","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bone.2019.115036_bb0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.0.CO;2-T","article-title":"Inhibitory effects of activin-a on osteoblast differentiation during cultures of fetal rat calvarial cells","volume":"75","author":"Ikenoue","year":"1999","journal-title":"J. Cell. Biochem."},{"issue":"26","key":"10.1016\/j.bone.2019.115036_bb0190","doi-asserted-by":"crossref","first-page":"11021","DOI":"10.1074\/jbc.M116.770941","article-title":"Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: a novel mechanism in muscle-bone communication","volume":"292","author":"Qin","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2019.115036_bb0195","series-title":"Annual European Calcified Tissue Society Congress, Bone Abstracts by Bioscientifica, Rome, Italy","first-page":"P158","article-title":"A single 2-day pulse of activin-A leads to a transient change in gene expression eventually followed by reduction in extracellular matrix mineralization","author":"Baroncelli","year":"2016"},{"issue":"1","key":"10.1016\/j.bone.2019.115036_bb0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/eje.0.1440063","article-title":"Expression and localization of activin receptors during endochondral bone development","volume":"144","author":"Funaba","year":"2001","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2019.115036_bb0205","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bbrc.2012.03.003","article-title":"Mechanisms involved in inhibition of chondrogenesis by activin-A","volume":"420","author":"Mitsugi","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bone.2019.115036_bb0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/08977194.2011.599324","article-title":"Myostatin (GDF-8) inhibits chondrogenesis and chondrocyte proliferation in vitro by suppressing Sox-9 expression","volume":"29","author":"Elkasrawy","year":"2011","journal-title":"Growth Factors"},{"issue":"2","key":"10.1016\/j.bone.2019.115036_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/scrt11","article-title":"Activin A expression regulates multipotency of mesenchymal progenitor cells","volume":"1","author":"Djouad","year":"2010","journal-title":"Stem Cell Res Ther"},{"issue":"23","key":"10.1016\/j.bone.2019.115036_bb0220","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1073\/pnas.89.23.11451","article-title":"Activin inhibits binding of transcription factor Pit-1 to the growth hormone promoter","volume":"89","author":"Struthers","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.bone.2019.115036_bb0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2012.01.025","article-title":"Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin","volume":"359","author":"Bilezikjian","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2019.115036_bb0230","first-page":"179","article-title":"Interferon-gamma and activin A promote insulin-like growth factor-binding protein-2 and -4 accumulation by human luteinizing granulosa cells, and interferon-gamma promotes their apoptosis","volume":"83","author":"Cataldo","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2019.115036_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180593","article-title":"Soluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model","volume":"12","author":"Puolakkainen","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bone.2019.115036_bb0240","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1210\/me.2008-0290","article-title":"Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators","volume":"22","author":"Souza","year":"2008","journal-title":"Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2019.115036_bb0245","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mus.23539","article-title":"A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers","volume":"47","author":"Attie","year":"2013","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.bone.2019.115036_bb0250","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/mus.25268","article-title":"Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: results of a randomized, placebo-controlled clinical trial","volume":"55","author":"Campbell","year":"2017","journal-title":"Muscle Nerve"},{"issue":"50","key":"10.1016\/j.bone.2019.115036_bb0255","doi-asserted-by":"crossref","first-page":"18117","DOI":"10.1073\/pnas.0505996102","article-title":"Regulation of muscle growth by multiple ligands signaling through activin type II receptors","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bone.2019.115036_bb0260","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.expneurol.2009.02.017","article-title":"A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis","volume":"217","author":"Morrison","year":"2009","journal-title":"Exp. Neurol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219303242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219303242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:13:15Z","timestamp":1778940795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219303242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":52,"alternative-id":["S8756328219303242"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.115036","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel ActRIIB ligand trap increases muscle mass and improves bone geometry in a mouse model of severe osteogenesis imperfecta","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.115036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115036"}}